Editorial
Opioids, Hypnotics and Muscle Relaxants: An Update on Pharmacokinetics and Techniques of Administration "So I think that the pharmacokinetic people have a big impact, people think now about decay curves and the rate at which they are decaying .. " Dr. Ted Stanley has correctly noted the influence that pharmacologists have had upon clinical anaesthetists; the availability of pharmacokinetic data has made possible the development of improved approaches to drug administration which can enhance the quality of care in a variety of clinical situations.
This symposium issue brings together presentations from two recent anaesthetic meetings: 'Infusion Anaesthesia and Analgesia', held in Melbourne, and 'Update on Opioids', in Sydney. The contributors have addressed aspects of both established and recently developed drugs used in anaesthetic practice and armed with such data have presented innovative techniques for relating mode of administration to the clinical circumstances and the desired effect. Needless to say, further data will become available and the techniques will be refined further. The possibilities emerging with the specificity of new synthetic opioids and the imaginative modes of administration may lead to an entirely new format for clinical practice by the turn of this century. However, if Australian anaesthetists are to participate in these developments and become familiar with these drugs, they will need to ensure a better anaesthetically in formed and empathetic Australian Drug Evaluation Committee.
Drugs can, in general, be divided into two main groups. The first group has low lipid solubility with varying clearance but, most significantly, small volumes of distributioh.
Anaesrhesia and Intensive Care, Vol. 15, No. /, February, 1987 This includes the antibiotics, skeletal muscle relaxants and many cardio-active agents, including vaso-active drugs, ganglion blockers and sodium nitroprusside. The kinetics of such drugs are readily represented by a singlecompartment model. Therapeutic infusions of these agents are achieved by administering a loading dose, followed by a fixed rate maintenance infusion, the rate derived by multiplying the expected clearance and the desired plasma concentration; alternatively, by titrating the infusion rate to produce the desired effect. The classic example of such an approach is a simple suxamethonium infusion, where an ordinary intravenous drip set can be used and the drop rate titrated to effect.
The second group includes more lipid solUble agents such as the barbiturates, opioids and tranquillisers. In this group, with larger volumes of distribution, the plasma concentration following an initial bolus falls within a very short time due to distribution. To maintain a therapeutic effect, there is an immediate need to augment the falling concentration with an infusion. A loading infusion or a variable rate infusion is required, as a fixed rate infusion would take about three elimination half-lives to fill the volume of distribution. Approaches to this technical problem are described in this issue by Stanksi and Crankshaw.
The indications for total infusion anaesthesia have increased in response to concerns about the safety of volatile anaesthetic agents. Organ toxicity, environmental pollution and cost are of particular concern. Inhalation anaesthesia tends to be unsuitable for laryngeal surgery and tracheal surgery and in association with laser techniq ues.
There remain continuing concerns, even with the newer volatile agents, about adverse effects on cerebral blood flow, intracranial pressure, impaired myocardial function and alteration of coronary blood flow. Cerebral protection can be achieved with infused agents. The opioids are particularly effective in reducing the stress response. Other applications for intravenous anaesthesia are the control of cardiovascular responses and arrhythmias and the continuing and well-established need for sedation of patients during procedures done under local or regional anaesthesia and endoscopies.
With the advent of the new muscle relaxants, there is also a pressing need to understand the pharmacokinetics of these agents to ensure that sudden spontaneous reversal of the paralysis does not occur. Infusion techniques may lessen the chance of this occurring and offer the opportunity of reducing the total dosage and cost by reducing peaks in plasma concentration.
